EMMAUS LIFE SCIENCES
Emmaus Life Sciences is engaged in the discovery, development, and commercialization of treatments and therapies primarily for rare and orphan diseases. Their focus has been on rare and orphan diseases, such as sickle cell disease. Their product candidate is an oral pharmaceutical grade L-glutamine treatment that demonstrated positive clinical results in their completed phase 3 clinical trial for sickle cell anemia and sickle ß0-thalassemia.
EMMAUS LIFE SCIENCES
Industry:
Biopharma Biotechnology Health Care Life Science
Founded:
2000-01-01
Address:
Torrance, California, United States
Country:
United States
Website Url:
http://www.emmausmedical.com
Total Employee:
11+
Status:
Active
Contact:
+1 310 214 0065
Email Addresses:
[email protected]
Total Funding:
110 K USD
Similar Organizations
Bond Biosciences
Bond Biosciences is a biopharmaceutical company
Harbor Launch
Community for early-stage life science and environmental companies
Oncoscience
Oncoscience is a biopharmaceutical company
Official Site Inspections
http://www.emmausmedical.com
- Host name: 104.43.142.33
- IP address: 104.43.142.33
- Location: Des Moines United States
- Latitude: 41.6006
- Longitude: -93.6112
- Metro Code: 679
- Timezone: America/Chicago
- Postal: 50307
More informations about "Emmaus Life Sciences"
Company Information :: Emmaus Life Sciences, Inc.
Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company engaged in the discovery, development, marketing and sale of innovative treatments and therapies, including those in the rare and orphan disease …See details»
Investor Relations :: Emmaus Life Sciences, Inc. (EMMA)
Nov 19, 2024 Company. Emmaus Life Sciences, Inc. 21250 Hawthorne Blvd. Suite 800 Torrance, CA 90503 T: 310-214-0065See details»
Emmaus Medical - Crunchbase Company Profile
Organization. Emmaus Medical . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Emmaus …See details»
Emmaus Medical, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Emmaus Medical, Inc. of Torrance, CA. Get the latest business insights from Dun & Bradstreet.See details»
Emmaus Life Sciences Reports Annual Financial Results for 2020 …
Dec 31, 2020 Direct Sales Force - Effective January 1, 2020, Emmaus switched from the use of a contract sales organization to its own direct sales force. The company currently has 23 …See details»
Overview - Emmaus Medical, Inc.
Emmaus Life Sciences, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of innovative treatments and therapies primarily for rare …See details»
Emmaus Life Sciences - Overview, News & Similar companies
Apr 15, 2024 Who is Emmaus Life Sciences. Founded in 2000, Emmaus Life Sciences, Inc. is engaged in the discovery, development and commercialization of innovative treatments and …See details»
FAQ :: Emmaus Life Sciences, Inc. (EMMA) - ir.emmausmedical.com
Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company engaged in the discovery, development, marketing and sale of innovative treatments and therapies, including …See details»
Mission - Emmaus Medical, Inc.
The mission of Emmaus Life Sciences is to improve the lives of people in need through the discovery, development and commercialization of innovative treatments and therapies.See details»
Emmaus Medical - The Org
Emmaus Life Sciences, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of innovative treatments and therapies primarily for rare and orphan diseases.See details»
Emmaus Medical (M269WMVERVY4) - highergov.com
Emmaus Medical (UEI M269WMVERVY4, CAGE 4KN12) based in Torrance CA federal contracts, grants, registrations, vehicles, partnerships, and analysisSee details»
Emmaus Medical - 2025 Company Profile - Tracxn
Mar 19, 2025 Emmaus Medical - Small molecule therapeutics for the treatment of sickle cell anemia and sickle ß0-thalassemia. Acquired by Generex Biotechnology. Raised funding over …See details»
Emmaus Life Sciences Reports Improved Quarterly Financial Results
Dec 31, 2023 Torrance CA, November 19, 2024 - Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle …See details»
Financial Results :: Emmaus Life Sciences, Inc. (EMMA)
Dec 31, 2024 Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company engaged in the discovery, development, marketing and sale of innovative treatments and …See details»
Emmaus Life Sciences Reports 2022 Financial Results and Provides ...
Mar 31, 2023 For more information, please visit www.emmausmedical.com. About Endari® (prescription grade L-glutamine oral powder) Endari®, Emmaus' prescription grade L …See details»
Financial Information :: Emmaus Life Sciences, Inc. (EMMA)
Dec 31, 2024 Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company engaged in the discovery, development, marketing and sale of innovative treatments and …See details»
Emmaus Life Sciences Reports 2024 Financial Results
Apr 14, 2025 For more information, please visit www.emmausmedical.com. About Endari® (prescription grade L-glutamine oral powder) Endari®, Emmaus' prescription grade L …See details»
Emmaus Life Sciences Reports 2024 Financial Results
Torrance CA, April 14 2025 - Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported …See details»
Emmaus Life Sciences Reports Q1 2023 Financial Results and …
Torrance CA, May 15, 2023 - Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported …See details»